Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHarvey Nash Group Regulatory News (HVN)

  • There is currently no data for HVN

Director/PDMR Shareholding

29 Oct 2018 07:00

RNS Number : 3880F
Harvey Nash Group PLC
29 October 2018
 

29 October 2018

 

Director/PDMR Shareholding

Harvey Nash Group Plc

("the Company")

Notification of Transaction by Directors

In accordance with DTR 3.1 and Article 19 of The Market Abuse Regulation, the Company was advised on 26 October 2018 that Albert Ellis, Simon Wassall and Mark Garratt had acquired ordinary shares in London on 26 October 2018 at a price of £0.05 per ordinary share as a result of the exercise of options granted under the Company's Performance Share Plan which became exercisable as a result of the offer by The Power of Talent Ltd being declared wholly unconditional on 26 October 2018:

Director

Number of shares purchased

Price per share

Resulting holding

Albert Ellis

1,385,499

£0.05

2,267,084*

Simon Wassall

930,215

£0.05

1,259,331

Mark Garratt

381,229

£0.05

416,787

*Includes 658,923 ordinary shares held by family members.

The notification below provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

1

Details of the person discharging managerial responsibility

a)

Name

Albert Ellis

2

Reason for the notification

a)

Position/status

Chief Executive

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

1,385,499

£69,274.95

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Simon Wassall

2

Reason for the notification

a)

Position/status

European Managing Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

930,215

£46,510.75

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Garratt

2

Reason for the notification

a)

Position/status

Group Finance Director

 

b)

Initial notification/amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Harvey Nash Group plc

b)

Legal Entity Identifier Code

2138004ULQUX3DQSCV07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05 each

ISIN: GB0006573546

c)

Nature of the transaction

Acquisition through Company Performance Share Plan.

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0.05

381,229

£19,061.45

 

 

 

g)

Date of transaction

26 October 2018

h)

Place of transaction

London Stock Exchange XLON

 

Contact:

Mark Garratt, Group Finance Director - 020 7333 0033

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFEUFMMFASEES
Date   Source Headline
1st Sep 20167:00 amRNSTotal Voting Rights
1st Aug 20167:00 amRNSTotal Voting Rights
29th Jul 20164:57 pmRNSDirector/PDMR Shareholding
1st Jul 20161:13 pmRNSDirector/PDMR Shareholding
1st Jul 20167:00 amRNSTotal Voting Rights
30th Jun 201612:21 pmRNSResults of AGM
30th Jun 20167:00 amRNSAGM Statement
17th Jun 201612:55 pmRNSShare Option Exercise and PDMR shareholding
13th Jun 20167:00 amRNSBlock listing Interim Review
1st Jun 20164:50 pmRNSDirector/PDMR Shareholding
1st Jun 20167:00 amRNSTotal Voting Rights
3rd May 201611:17 amRNSDirector/PDMR Shareholding
3rd May 20167:00 amRNSTotal Voting Rights
29th Apr 20165:05 pmRNSHolding(s) in Company
29th Apr 20162:24 pmRNSGrant of Share Awards to Directors
28th Apr 20167:00 amRNSFinal Results
14th Apr 201610:28 amRNSNotice of Adoption of FRS 101
1st Apr 20167:00 amRNSTotal Voting Rights
30th Mar 20163:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20169:26 amRNSDirector/PDMR Shareholding
1st Mar 20167:00 amRNSTotal Voting Rights
26th Feb 20167:00 amRNSPre-close Trading Update and Notice of Results
1st Feb 20167:00 amRNSTotal Voting Rights
29th Jan 20169:54 amRNSDirector/PDMR Shareholding
15th Jan 20163:19 pmRNSHolding(s) in Company
4th Jan 20167:00 amRNSTotal Voting Rights
24th Dec 20159:28 amRNSDirector/PDMR Shareholding
18th Dec 20151:08 pmRNSBlocklisting Interim Review
7th Dec 20158:49 amRNSHolding(s) in Company
7th Dec 20157:00 amRNSTrading Update and Disposal
1st Dec 20157:00 amRNSTotal Voting Rights
30th Nov 20154:57 pmRNSDirector/PDMR Shareholding
3rd Nov 20159:28 amRNSDirector/PDMR Shareholding
2nd Nov 20157:00 amRNSTotal Voting Rights
6th Oct 201511:12 amRNSHolding(s) in Company
1st Oct 20157:00 amRNSTotal Voting Rights
30th Sep 20157:00 amRNSInterim Results
29th Sep 20152:18 pmRNSDirector/PDMR Shareholding
17th Sep 20155:07 pmRNSHolding(s) in Company
2nd Sep 201510:09 amRNSDirector/PDMR Shareholding
1st Sep 20157:03 amRNSTotal Voting Rights
3rd Aug 20157:00 amRNSTotal Voting Rights
31st Jul 20159:41 amRNSDirector/PDMR Shareholding
3rd Jul 20152:49 pmRNSBlocklisting Interim Review
2nd Jul 201512:16 pmRNSResult of AGM
2nd Jul 20157:00 amRNSAGM - Trading Statement
1st Jul 20157:00 amRNSTotal Voting Rights
30th Jun 201512:49 pmRNSDirector/PDMR Shareholding
9th Jun 20154:18 pmRNSHolding(s) in Company
1st Jun 20157:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.